Colorectal Liver Metastases: A Changing Treatment Landscape [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Brudvik, K. W., Passot, G., Vauthey, J.-N. Tags: Surgery, Surgical Oncology, Surgical Oncology COMMENTARIES Source Type: research
Surgical Management of Liver Metastases From Colorectal Cancer [Clinical Reviews]
This article provides an overview of the surgical management of colorectal liver metastases. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Dhir, M., Sasson, A. R. Tags: Surgery, Surgical Oncology Clinical Reviews Source Type: research
Early Detection and Treatment Opportunities in Pancreatic Adenocarcinoma [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: OReilly, E. M. Tags: Translational Oncology COMMENTARIES Source Type: research
Pancreatic Adenocarcinoma: The Emperor of All Cancer Maladies [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Tempero, M. Tags: Chemotherapy, Translational Oncology COMMENTARIES Source Type: research
Clinical Insights Into the Biology and Treatment of Pancreatic Cancer [Clinical Reviews]
Pancreatic cancer is a devastating disease with a universally poor prognosis. In 2015, it is estimated that there will be 48,960 new cases of pancreatic cancer and that 40,560 people will die of the disease. The 5-year survival rate is 7.2% for all patients with pancreatic cancer; however, survival depends greatly on the stage at diagnosis. Unfortunately, 53% of patients already have metastatic disease at diagnosis, which corresponds to a 5-year survival rate of 2.4%. Even for the 9% of patients with localized disease confined to the pancreas, the 5-year survival is still modest at only 27.1%. These grim statistics highlig...
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Mettu, N. B., Abbruzzese, J. L. Tags: Translational Oncology, Signal Transduction, Tumor Suppressors, Gastrointestinal, Growth Factors & Receptor, Oncogenes Clinical Reviews Source Type: research
Is Breast Cancer a Curable Disease? [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Hayes, D. F. Tags: Caregiver, Translational Oncology COMMENTARIES Source Type: research
Conquering Metastatic Breast Cancer [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Davidson, N. E. Tags: Diagnosis & Staging COMMENTARIES Source Type: research
Curing Metastatic Breast Cancer [Clinical Reviews]
This article outlines a potential research agenda that might move us toward that distant goal. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Sledge, G. W. Tags: Chemotherapy, Combined Modality, Hormonal Therapy Clinical Reviews Source Type: research
A Snapshot of the State of Cancer Care in America [Practice Dashboard]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Towle, E. L. Tags: Practice Dashboard Source Type: research
Evolution [Editor's Desk]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Cox, J. V., Armitage, J. O. Tags: Editor ' s Desk Source Type: research
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline [Guideline Summaries]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - November 13, 2015 Category: Cancer & Oncology Authors: Van Poznak, C., Harris, L. N., Somerfield, M. R. Tags: Clinical guidelines, Management and treatment, Quality of care, Clinical guidelines, Epidemiology, ASCO Guidelines, Quality of Life, Quality of Care, Guidelines Guideline Summaries Source Type: research
Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update [Guideline Summaries]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - November 13, 2015 Category: Cancer & Oncology Authors: Smith, T. J., Bohlke, K., Armitage, J. O. Tags: Clinical guidelines, Complications of cancer and cancer treatment, Treatment related issues, Palliative care, Quality of care, Growth Factors, Supportive Care, ASCO Guidelines Guideline Summaries Source Type: research
Complications Associated With Use of Long-Term Central Venous Catheters Among Commercially Insured Women With Breast Cancer [Original Contributions]
Conclusion:
Although long-term CVCs may have benefits, they are associated with increased morbidity. Regional and health plan variation in long-term CVC insertion suggests that some of their use reflects provider- or institution-driven variation in practice. Evidence-based guidelines and tools may help decrease discretionary use of long-term CVCs. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - November 13, 2015 Category: Cancer & Oncology Authors: Lipitz-Snyderman, A., Ma, Q., Pollack, M. F., Barron, J., Elkin, E. B., Bach, P. B., Malin, J. L. Tags: Patient safety, Complications of cancer and cancer treatment, Treatment related issues, Quality, Patient safety, Quality of care, Population and Observational Studies, Outcomes Research, Quality of Care Original Contributions Source Type: research
Oral Anticancer Medication Adherence, Toxicity Reporting, and Counseling: A Study Comparing Health Care Providers and Patients [Original Contributions]
Conclusion:
This study highlights disparities in patient and HCP perceptions of OACM adherence principles and toxicity reporting. Opportunities for improved patient education are identified, particularly around reporting significant toxicities. Different HCPs may benefit from complimentary counseling tools to encompass the entire spectrum of patient needs and provider practice. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - November 13, 2015 Category: Cancer & Oncology Authors: Gandhi, S., Day, L., Paramsothy, T., Giotis, A., Ford, M., Boudreau, A., Pasetka, M. Tags: Doctor-patient communication, Management and treatment, Complications of cancer and cancer treatment, Treatment related issues, Quality, Patient safety, Quality of care, General public, Patient, Management and treatment, Survivor, Patient safety, Access t Source Type: research
Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World Practice [Original Contributions]
Conclusion:
Patients with mRCC treated with tyrosine kinase inhibitors in real-world clinical practice are sicker than those enrolled onto pivotal clinical trials, and more than one third are trial ineligible. Application of clinical trial findings to dissimilar populations may result in patient harm. Clinical research with more inclusive eligibility criteria is needed to appropriately guide real-world practice. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - November 13, 2015 Category: Cancer & Oncology Authors: Mitchell, A. P., Harrison, M. R., Walker, M. S., George, D. J., Abernethy, A. P., Hirsch, B. R. Tags: Methodology, Systemic Therapy, Clinical Trials Original Contributions Source Type: research
